Michael Thomas Heffernan, Director: Trevi Therapeutics TRVI Planned sale · Filed 09/15

Trade details

Type: Planned sale notice
Stock: Trevi Therapeutics TRVI
Person: Michael Thomas HeffernanDirector
Planned sale date: 26/09/15
Filed: 26/09/15

$627.2K to be sold

Trevi Therapeutics trades, last 26 weeks

What else happened in Trevi Therapeutics around then

Filed or reported within 30 days of the trade day · 08/16~10/15

Michael Thomas Heffernan's recent trades

Michael Thomas HeffernanFormer Director
Planned saleCollegium Pharmaceutical
Planned sale
Collegium Pharmaceutical
COLL
$332.3K
10,328 sh
$332.3K
Filed 25/07/09
Traded 25/07/09
Michael Thomas HeffernanFormer Director
Planned saleCollegium Pharmaceutical
Planned sale
Collegium Pharmaceutical
COLL
$24.8K
790 sh
$24.8K
Filed 25/07/08
Traded 25/07/08
Michael Thomas HeffernanFormer Director
Planned saleCollegium Pharmaceutical
Planned sale
Collegium Pharmaceutical
COLL
$444.1K
14,210 sh
$444.1K
Filed 25/07/07
Traded 25/07/07
Michael Thomas HeffernanFormer Director
Planned saleCollegium Pharmaceutical
Planned sale
Collegium Pharmaceutical
COLL
$757.4K
25,000 sh
$757.4K
Filed 25/07/02
Traded 25/07/02

Michael Thomas Heffernan, Director — plans to sell 39,473 sh of Trevi Therapeutics TRVI · $627.2K · around 09/15 · 10b5-1 plan | Whalegun